These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28275351)

  • 1. Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders.
    Alfonsi E; Restivo DA; Cosentino G; De Icco R; Bertino G; Schindler A; Todisco M; Fresia M; Cortese A; Prunetti P; Ramusino MC; Moglia A; Sandrini G; Tassorelli C
    Front Pharmacol; 2017; 8():80. PubMed ID: 28275351
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and implementation of botulinum toxin on cricopharyngeal dysfunction guided by a combination of catheter balloon, ultrasound, and electromyography (BECURE) in patients with stroke: study protocol for a randomized, double-blinded, placebo-controlled trial.
    Xie M; Dou Z; Wan G; Zeng P; Wen H
    Trials; 2021 Mar; 22(1):238. PubMed ID: 33789722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison studies of ultrasound-guided botulinum toxin injection and balloon catheter dilatation in the treatment of neurogenic cricopharyngeal muscle dysfunction.
    Luan S; Wu SL; Xiao LJ; Yang HY; Liao MX; Wang SL; Fan SN; Ma C
    NeuroRehabilitation; 2021; 49(4):629-639. PubMed ID: 34806624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment.
    Alfonsi E; Merlo IM; Ponzio M; Montomoli C; Tassorelli C; Biancardi C; Lozza A; Martignoni E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):54-60. PubMed ID: 19762326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Combined Guidance of Botulinum Toxin Injection with Ultrasound, Catheter Balloon, and Electromyography on Neurogenic Cricopharyngeal Dysfunction: A Prospective Study.
    Xie M; Zeng P; Wan G; An D; Tang Z; Li C; Wei X; Shi J; Zhang Y; Dou Z; Wen H
    Dysphagia; 2022 Jun; 37(3):601-611. PubMed ID: 33928464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study.
    Terre R; Valles M; Panades A; Mearin F
    Scand J Gastroenterol; 2008; 43(11):1296-303. PubMed ID: 18649151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrokinesiographic Study of Oropharyngeal Swallowing in Neurogenic Dysphagia.
    Alfonsi E; Todisco M; Fresia M; Tassorelli C; Cosentino G
    Dysphagia; 2023 Apr; 38(2):543-557. PubMed ID: 34313849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic botulinum toxin injection combined with balloon dilatation for treatment of cricopharyngeal achalasia in patient with brainstem stroke.
    Liu C; Li Y; Tan Z; Liu H; Zhou M; Li J; Liang J; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1203-1209. PubMed ID: 37875360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.
    Kelly EA; Koszewski IJ; Jaradeh SS; Merati AL; Blumin JH; Bock JM
    Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):100-8. PubMed ID: 23534124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A injection using ultrasound combined with balloon guidance for the treatment of cricopharyngeal dysphagia: analysis of 21 cases.
    Zhu L; Chen J; Shao X; Pu X; Zheng J; Zhang J; Wu X; Wu D
    Scand J Gastroenterol; 2022 Jul; 57(7):884-890. PubMed ID: 35213271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.
    Wei P
    Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound, electromyography, and balloon guidance for injecting botulinum toxin for cricopharyngeal achalasia: A case report.
    Chen JM; Chen YJ; Ni J; Wang ZY
    Medicine (Baltimore); 2021 Mar; 100(11):e24909. PubMed ID: 33725963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke.
    Terré R; Panadés A; Mearin F
    Neurogastroenterol Motil; 2013 Nov; 25(11):896-e702. PubMed ID: 23991889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A injection of UES in schizencephaly with dysphagia: Case report.
    Nam KY; Kim C; Park JW; Lee HJ; Kwon BS
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1935-7. PubMed ID: 26351064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphagia in neurological diseases: a literature review.
    Panebianco M; Marchese-Ragona R; Masiero S; Restivo DA
    Neurol Sci; 2020 Nov; 41(11):3067-3073. PubMed ID: 32506360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction.
    Kim DY; Park CI; Ohn SH; Moon JY; Chang WH; Park SW
    Arch Phys Med Rehabil; 2006 Oct; 87(10):1346-51. PubMed ID: 17023244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
    Alfonsi E; Bergamaschi R; Cosentino G; Ponzio M; Montomoli C; Restivo DA; Brighina F; Ravaglia S; Prunetti P; Bertino G; Benazzo M; Fontana D; Moglia A
    Clin Neurophysiol; 2013 Aug; 124(8):1638-45. PubMed ID: 23601703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders.
    Vanuytsel T; Bisschops R; Farré R; Pauwels A; Holvoet L; Arts J; Caenepeel P; De Wulf D; Mimidis K; Rommel N; Tack J
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1115-1121.e2. PubMed ID: 23591282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of upper esophageal sphincter disorders: indications and complications of myotomy.
    Kelly JH
    Am J Med; 2000 Mar; 108 Suppl 4a():43S-46S. PubMed ID: 10718451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Post COVID-19 Neurogenic Dysphagia with Botulinum Toxin.
    Canta R; Vestito L; Castellini P; Trompetto C; Mori L; De Giovanni A; Puce L; Marinelli L
    Eur J Case Rep Intern Med; 2023; 10(12):004105. PubMed ID: 38077706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.